Skip to search formSkip to main contentSkip to account menu

Glycosylation End Products, Advanced

Known as: Advanced Glycation End Products, Advanced Glycation End-Product, Advanced Glycation Endproducts 
Products derived from the nonenzymatic reaction of GLUCOSE and PROTEINS in vivo that exhibit a yellow-brown pigmentation and an ability to… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Mapanga RF, Essop MF. Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways. Am J… 
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Type 2 diabetes is associated with chronic low-grade inflammation, but the underlying mechanism(s) is not well… 
Highly Cited
1999
Highly Cited
1999
Advanced glycation end products (AGEs) have been implicated as causal factors in the vascular complications of diabetes and it is… 
Highly Cited
1999
Highly Cited
1999
Aims/hypothesis. We investigated whether either the amount of diabetes-induced intracellular oxidative stress or the… 
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To investigate whether children and adolescents with type 1 diabetes have increased serum levels of the glycoxidation… 
Highly Cited
1997
Highly Cited
1997
Summary Advanced glycation end products (AGEs) have previously been shown to be increased in the diabetic kidney. Aminoguanidine… 
Highly Cited
1995
Highly Cited
1995
The influence of advanced glycosylation end products (AGE) on bovine retinal pericytes was investigated. When pericytes were… 
Review
1988
Review
1988
Glucose and other reducing sugars can react with proteins and nucleic acids, without the aid of enzymes, to form stable covalent… 
Highly Cited
1988
Highly Cited
1988
A high-affinity macrophage receptor has been shown to mediate the removal of proteins modified by advanced nonenzymatic…